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  We developed an excitation laser and the spectrophotometer for the fluorescent 
diagnosis of tumor in the case of 5-ALA as shown in Figure 4. In actual, the removed 
tissue of glioblastoma was emitted the red fluorescence image shown in Figure 1 of 
Pp-IX 4hr after the oral administration of 5-ALA aqueous solution before the operation. 
Especially, in the labeled position of 1 area in the white light image (left upper image) of 
the GBM is emitted red as shown in the fluorescence image (right bottom image) will be 
fallen behind to remove in white light on the surgical operation.  
Figure 1. 
（Dr. Kaneko）
Removed Tissue of GBM and the Fluorescent 
Image of Pp-IX 4 hr Oral Administration of 
5-ALA aqueous solution before the Operation
 
  On the other hand, we take to move on the PDT studies. The excitation spectrum of 
Pp-IX were changed from pattern A to B during the irradiation at 635 nm for 40J in the 
HL-60 cells suspension incorporated 5-ALA as shown in Figure 7. We observed the 
changing spectra (from A to B) of Pp-IX photoproduct during photo-irradiation At the 
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wavelength range more than 600 nm, the pair of fluorescence excitation (ex) and 
emission (em) spectra of A (Pp-IX) and B (photoproduct of Pp-IX) were normalized at the 
each peaks as shown in Figure 2. In actual, the excitation peak at 630 nm was 
decreasing with increasing the excitation peak at 665 nm during the photo-irradiation. 
As it has been reported about the photoproducts of Pp-IX by many researchers, chlorine 
derivative by Moan group (1, 2, 3), we can also estimate that it will be a chlorine-like 
derivative from the matting with the excitation (665 nm) and emission (670 nm) peaks 
of the derivative. Furthermore, the product plays photoactive as a photosensitizer as 
following figures. On the other hand, it was reported that the photoproduct will a 
hydroxyl aldehyde derivative of Pp-IX reported by Dietel, et al. (4) as the product of 
Pp-IX. 
Figure 2. 
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Changing Spectra of Pp-IX Photoproduct during Photoirradiation
 
  We developed a dual-color (635, 670 nm) diode laser system (DLD-R2) produced from 
SMI-ALApromo Ltd. Co. (Tokyo) in Figure 8. Furthermore, we developed a new disk 
pulsed laser for three wavelengths at 659, 664, and 669 nm as shown in Figure 9. These 
laser will be used for the photoproduct of Pp-IX. We has developed a LD pulsed double 
(635 and 665 nm) laser made by hand as shown in Figure 10. On the CW laser, the 
longer wavelength laser beam enhanced the PDT effect of tumor in the case of shorter 
wavelength irradiation at 635 nm only. 
 
 
 
 
 
 
3 
 
 
Figure 3. 
LD Pulsed Double Laser
(Hand made, 635+665 nm)
Pulse 
Generator
Double (635, 
665 nm) 
LD Laser
 
Figure 4. 
LD Double Pulsed Laser (635, 670 nm)
(Experimental Tumor Model, SCC on C3H/He Mouse)
5-ALA
+635nm
5-ALA/TiO2
+635+CW670 nm
5-ALA/TiO2
+635+Pulsed 670 nm
Control
5-ALA/TiO2
+635nm
N=5 / 1group
CW635nm:150mW  150J Irrad.
CW670nm・pulsed laser：150mW 150J Irrad.
 
  In the case of using the TiO2 particles, we have applied the ultrasound irradiation 
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treatments for the experimental tumor model combined with PDT by the instruments 
(G:generator,  A:amplifier, C:cooling water, and P:ultrasound probe) as shown in 
Figure 13. As we expected the cavitations effect by ultrasound against the particles, we 
irradiated the ultrasound (1MHz) for 10 min combined with PDT as shown in Figure 13. 
It was identified that the enhancing antitumor effects by ultrasound and PDT-combined  
TiO2 particles, see Figure 5. 
Figure 5. 
Tumor volume changing after PDT
Control
5-ALA
+US
5-ALA/TiO2
5-ALA/TiO2
+US
N=5 / 1group
CW635nm:150mW 150J Irrad./cm2
US 1MHz 10min Irrad.
 
  In future, we are continuing to apply the other combination therapy with PDT against 
the animal tumor models. 
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